Enzon Pharmaceuticals, INC. (ENZN) — 10-K/A Filings

All 10-K/A filings from Enzon Pharmaceuticals, INC.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (2)

Enzon Pharmaceuticals Files 10-K/A Amendment for Part III Info — Apr 28, 2025 Risk: low
Enzon Pharmaceuticals, Inc. is filing an amendment (10-K/A) to its annual report for the year ended December 31, 2024. This amendment, filed on April 28, 2025,
Enzon Pharmaceuticals Files 10-K/A Amendment for Fiscal Year Ended December 31, 2023 — Apr 26, 2024 Risk: low
ENZON PHARMACEUTICALS, INC. (ENZN) filed a Amended Annual Report (10-K/A) with the SEC on April 26, 2024. Enzon Pharmaceuticals, Inc. filed a 10-K/A (Amendment

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX